Clinical Laboratory Services to improve patient outcomes
High-Complexity Testing for Precision Medicine
Our CAP-accredited and CLIA-licensed laboratory delivers high-complexity testing solutions designed to support the diagnosis, monitoring, and management of complex diseases—particularly in oncology (including multiple myeloma), autoimmune disorders, and rare conditions.
Leveraging deep expertise in protein analysis and mass spectrometry, we provide highly sensitive and specific assays that enable clinicians to make informed treatment decisions and improve patient outcomes.
Actionable Insights for Better Care
We support clinicians with reliable, high-quality diagnostic data to inform treatment strategies and ongoing disease management.
Our testing capabilities are designed to:
– Enable earlier and more accurate detection of disease relapse
– Monitor disease progression and depth of treatment response
– Support personalized therapeutic decision-making
Clearer Insights. Better Disease Management.
We provide advanced, minimally invasive testing that enables more frequent and informative monitoring of disease.
Our approach supports:
– Blood-based monitoring of minimal residual disease (MRD)
– More frequent testing to track disease status over time
– Improved visibility into treatment effectiveness
By delivering precise and consistent results, we help clinicians better guide each patient’s treatment journey and improve overall outcomes.
Enabling Clinical Trials and Translational Research
Corgenix is a trusted partner for pharmaceutical and biotechnology companies seeking high-quality laboratory support for clinical development.
We provide specialized testing services for:
– Clinical trials (Phase I–IV)
– Investigator-initiated studies
Our expertise in proteomics and mass spectrometry enables the generation of robust, reproducible data critical to advancing therapeutic programs and supporting regulatory success.